
	Mr. Michael A. Kelly has been Acting Chief Financial Officer of Amgen Inc. since January 10, 2014. Previously, Mr. Kelly served as Acting Chief Financial Officer of Amgen Inc. from May 12, 2010 to September 1, 2010. He served as the Chief Accounting Officer and Vice President of Corporate Planning and Control of Amgen Inc. since August 10, 2005 until May 12th 2010. Mr. Kelly served as Vice President of Finance for Process Development, Operations and Quality at Amgen Inc. Mr. Kelly joined Amgen Inc. in early 2003 as Vice President of Finance. From 2000 to 2002, Mr. Kelly served as Vice President of Finance and Chief Financial Officer of Tanox Inc. Before joining Tanox, he served as Vice President and Corporate Controller of Biogen Inc. since August 1998 to 2000, where he was responsible for worldwide financial strategy and organizational development and led a 75-person global team. While at Biogen, he was responsible for an immediate improvement in the credibility of the Corporate Controller role and reputation of the finance function through a service-oriented presence in the business. Prior to that, he held numerous senior management positions with Monsanto Life Sciences Company from 1981 to 1998, including Vice President of Finance. Mr. Kelly holds a BS in Business Administration from Florida A&amp;M University.
